CLINICAL_TRIALS
trial_result
· 2009-08-11
Clinical Trial Update: Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma [Phase 3]
Summary
A Phase 3 clinical trial assessing GW815SF HFA MDI in pediatric patients with bronchial asthma has completed. Results were posted in August 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED | Results posted: 2009-08-11